• 2024
  Wu Y, Liu C, Tang C, Niragire B, Levy-Zauberman Y, Adapen C, Vernay T, Hugueny J, Baud V, Subtil A, Chlamydia-driven ISG15 expression dampens the immune response of epithelial cells independently of ISGylation., mBio 2024 Sep; (): e0240124.
• 2022
  Jani RA, Di Cicco A, Keren-Kaplan T, Vale-Costa S, Hamaoui D, Hurbain I, Tsai FC, Di Marco M, Macé AS, Zhu Y, Amorim MJ, Bassereau P, Bonifacino JS, Subtil A, Marks MS, Lévy D, Raposo G, Delevoye C, , PI4P and BLOC-1 remodel endosomal membranes into tubules., J Cell Biol 2022 Nov; 221(11):e202110132.
• 2022
  N'Gadjaga MD, Perrinet S, Connor MG, Bertolin G, Millot GA, Subtil A, , Chlamydia trachomatis development requires both host glycolysis and oxidative phosphorylation but has only minor effects on these pathways., J Biol Chem 2022 Aug; 298(9): 102338.
• 2022
  Triboulet S, N'Gadjaga MD, Niragire B, Köstlbacher S, Horn M, Aimanianda V, Subtil A, , CT295 Is Chlamydia trachomatis’ Phosphoglucomutase and a Type 3 Secretion Substrate., Front Cell Infect Microbiol 2022 ; 12(): 866729.
• 2021
  Zahradník J, Dey D, Marciano S, Kolářová L, Charendoff CI, Subtil A, Schreiber G, , A Protein-Engineered, Enhanced Yeast Display Platform for Rapid Evolution of Challenging Targets., ACS Synth Biol 2021 Dec; 10(12): 3445-3460.
• 2021
  Hamaoui D, Subtil A, , ATG16L1 functions in cell homeostasis beyond autophagy., FEBS J 2022 Apr; 289(7): 1779-1800.
• 2021
  Tang C, Liu C, Maffei B, Niragire B, Cohen H, Kane A, Donnadieu AC, Levy-Zauberman Y, Vernay T, Hugueny J, Vincens E, Louis-Sylvestre C, Subtil A, Wu Y, , Primary ectocervical epithelial cells display lower permissivity to Chlamydia trachomatis than HeLa cells and a globally higher pro-inflammatory profile., Sci Rep 2021 03; 11(1): 5848.
• 2020
  Hamaoui D, Cossé MM, Mohan J, Lystad AH, Wollert T, Subtil A, , The Chlamydia effector CT622/TaiP targets a nonautophagy related function of ATG16L1., Proc Natl Acad Sci U S A 2020 10; 117(43): 26784-26794.
• 2020
  Maffei B, Laverrière M, Wu Y, Triboulet S, Perrinet S, Duchateau M, Matondo M, Hollis RL, Gourley C, Rupp J, Keillor JW, Subtil A, , Infection-driven activation of transglutaminase 2 boosts glucose uptake and hexosamine biosynthesis in epithelial cells., EMBO J 2020 04; 39(8): e102166.
• 2020
  Hänsch S, Spona D, Murra G, Köhrer K, Subtil A, Furtado AR, Lichtenthaler SF, Dislich B, Mölleken K, Hegemann JH, Chlamydia-induced curvature of the host-cell plasma membrane is required for infection, Proc Natl Acad Sci U S A. 2020 Feb 4;117(5):2634-2644.
• 2019
  Triboulet S, Subtil A, Make It a Sweet Home: Responses of to the Challenges of an Intravacuolar Lifestyle, Microbiol Spectr 2019 03;7(2).
• 2018
  Cossé MM, Barta ML, Fisher DJ, Oesterlin LK, Niragire B, Perrinet S, Millot GA, Hefty PS, Subtil A, The Loss of Expression of a Single Type 3 Effector (CT622) Strongly Reduces Infectivity and Growth, Front Cell Infect Microbiol 2018;8:145.
• 2017
  Cenci U, Bhattacharya D, Weber AP, Colleoni C, Subtil A, Ball SG, Biotic Host-Pathogen Interactions As Major Drivers of Plastid Endosymbiosis, Trends Plant Sci. 2017 Jan;.
• 2016
  François Vromman, Stéphanie Perrinet, Lena Gehre, Agathe Subtil., The DUF582 proteins of Chlamydia trachomatis bind to components of the ESCRT machinery, which is dispensable for bacterial growth in vitro., Front Cell Infect Microbiol. 2016 Sept;in press.
• 2016
  Chu J, Zhang Q, Zhang T, Han E, Zhao P, Khan A, He C, Wu Y, Chlamydia psittaci infection increases mortality of avian influenza virus H9N2 by suppressing host immune response, Sci Rep 2016 Jul;6:29421.
• 2016
  Gehre L, Gorgette O, Perrinet S, Prevost MC, Ducatez M, Giebel AM, Nelson DE, Ball SG, Subtil A, Sequestration of host metabolism by an intracellular pathogen, Elife 2016 Mar;5:e12552.
• 2014
  Domman D, Collingro A, Lagkouvardos I, Gehre L, Weinmaier T, Rattei T, Subtil A, Horn M, Massive expansion of Ubiquitination-related gene families within the Chlamydiae, Mol. Biol. Evol. 2014 Nov;31(11):2890-904.
• 2014
  Nawrotek A, Guimarães BG, Velours C, Subtil A, Knossow M, Gigant B, Biochemical and structural insights into microtubule perturbation by CopN from Chlamydia pneumoniae, J. Biol. Chem. 2014 Sep;289(36):25199-210.
• 2014
  Vromman F, Laverrière M, Perrinet S, Dufour A, Subtil A, Quantitative monitoring of the Chlamydia trachomatis developmental cycle using GFP-expressing bacteria, microscopy and flow cytometry, PLoS ONE 2014;9(6):e99197.
• 2014
  Steele-Mortimer O, Subtil A, Editorial overview: Host-microbe interactions: bacteria. War and peace: the fragile equilibrium between bacteria and host, Curr. Opin. Microbiol. 2014 Feb;17:v-vii.
• 2014
  Boncompain G, Müller C, Meas-Yedid V, Schmitt-Kopplin P, Lazarow PB, Subtil A, The intracellular bacteria Chlamydia hijack peroxisomes and utilize their enzymatic capacity to produce bacteria-specific phospholipids, PLoS ONE 2014;9(1):e86196.
• 2013
  Vromman F, Subtil A, Exploitation of host lipids by bacteria, Curr. Opin. Microbiol. 2014 Feb;17:38-45.
• 2013
  Subtil A, Collingro A, Horn M, Tracing the primordial Chlamydiae: extinct parasites of plants?, Trends Plant Sci. 2014 Jan;19(1):36-43.
• 2013
  Furtado AR, Essid M, Perrinet S, Balañá ME, Yoder N, Dehoux P, Subtil A, The chlamydial OTU domain-containing protein ChlaOTU is an early type III secretion effector targeting ubiquitin and NDP52, Cell. Microbiol. 2013 Dec;15(12):2064-79.
• 2013
  Ball SG, Subtil A, Bhattacharya D, Moustafa A, Weber AP, Gehre L, Colleoni C, Arias MC, Cenci U, Dauvillée D, Metabolic effectors secreted by bacterial pathogens: essential facilitators of plastid endosymbiosis?, Plant Cell 2013 Jan;25(1):7-21.
• 2012
  Ouellette SP, Karimova G, Subtil A, Ladant D, Chlamydia co-opts the rod shape-determining proteins MreB and Pbp2 for cell division, Mol. Microbiol. 2012 Jul;85(1):164-78.
• 2012
  Bierne H, Travier L, Mahlakõiv T, Tailleux L, Subtil A, Lebreton A, Paliwal A, Gicquel B, Staeheli P, Lecuit M, Cossart P, , Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta., PLoS One 2012 ; 7(6): e39080.
• 2011
  Subtil A, Rerouting of host lipids by bacteria: are you CERTain you need a vesicle?, PLoS Pathog. 2011 Sep;7(9):e1002208.
• 2011
  Dehoux P, Flores R, Dauga C, Zhong G, Subtil A, Multi-genome identification and characterization of chlamydiae-specific type III secretion substrates: the Inc proteins, BMC Genomics 2011;12:109.
• 2010
  Muschiol S, Boncompain G, Vromman F, Dehoux P, Normark S, Henriques-Normark B, Subtil A, Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae, Infect. Immun. 2011 Feb;79(2):571-80.
• 2010
  Pennini ME, Perrinet S, Dautry-Varsat A, Subtil A, Histone methylation by NUE, a novel nuclear effector of the intracellular pathogen Chlamydia trachomatis, PLoS Pathog. 2010;6(7):e1000995.
• 2009
  Boncompain G, Schneider B, Delevoye C, Kellermann O, Dautry-Varsat A, Subtil A, Production of reactive oxygen species is turned on and rapidly shut down in epithelial cells infected with Chlamydia trachomatis, Infect. Immun. 2010 Jan;78(1):80-7.
• 2009
  Paumet F, Wesolowski J, Garcia-Diaz A, Delevoye C, Aulner N, Shuman HA, Subtil A, Rothman JE, Intracellular bacteria encode inhibitory SNARE-like proteins, PLoS ONE 2009 Oct;4(10):e7375.
• 2009
  Muschiol S, Normark S, Henriques-Normark B, Subtil A, Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cells, BMC Microbiol. 2009;9:75.
• 2008
  Delevoye C, Nilges M, Dehoux P, Paumet F, Perrinet S, Dautry-Varsat A, Subtil A, SNARE protein mimicry by an intracellular bacterium, PLoS Pathog. 2008 Mar;4(3):e1000022.
• 2006
  Ménard A, Clerc M, Subtil A, Mégraud F, Bébéar C, de Barbeyrac B, Development of a real-time PCR for the detection of Chlamydia psittaci, J. Med. Microbiol. 2006 Apr;55(Pt 4):471-3.
• 2006
  de Cremoux P, Subtil A, Ferreri AJ, Vincent-Salomon A, Ponzoni M, Chaoui D, Arnaud P, Lumbroso-Le Rouic L, Sacchetti F, Dendale R, Thioux M, Escande MC, Stern MH, Dolcetti R, Decaudin D, Re: Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas, J. Natl. Cancer Inst. 2006 Mar;98(5):365-6.
• 2006
  Wyplosz B, Montalescot G, Subtil A, Dujeancourt A, Tanguy ML, Choussat R, Capron L, Dautry-Varsat A, Correlation between Chlamydia pneumoniae detection from coronary angioplasty balloons and atherosclerosis severity, J. Am. Coll. Cardiol. 2006 Mar;47(6):1229-31.
• 2005
  Dautry-Varsat A, Subtil A, Hackstadt T, Recent insights into the mechanisms of Chlamydia entry, Cell. Microbiol. 2005 Dec;7(12):1714-22.
• 2005
  Subtil A, Delevoye C, Balañá ME, Tastevin L, Perrinet S, Dautry-Varsat A, A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates, Mol. Microbiol. 2005 Jun;56(6):1636-47.
• 2005
  Balañá ME, Niedergang F, Subtil A, Alcover A, Chavrier P, Dautry-Varsat A, ARF6 GTPase controls bacterial invasion by actin remodelling, J. Cell. Sci. 2005 May;118(Pt 10):2201-10.
• 2004
  Delevoye C, Nilges M, Dautry-Varsat A, Subtil A, Conservation of the biochemical properties of IncA from Chlamydia trachomatis and Chlamydia caviae: oligomerization of IncA mediates interaction between facing membranes, J. Biol. Chem. 2004 Nov;279(45):46896-906.
• 2004
  Subtil A, Wyplosz B, Balañá ME, Dautry-Varsat A, Analysis of Chlamydia caviae entry sites and involvement of Cdc42 and Rac activity, J. Cell. Sci. 2004 Aug;117(Pt 17):3923-33.
• 2004
  Subtil A, Dautry-Varsat A, Chlamydia: five years A.G. (after genome), Curr. Opin. Microbiol. 2004 Feb;7(1):85-92.